FTC accuses Martin Shkreli of violating lifetime pharma ban

RegulatoryNegative

AI Analysis

Summary

The FTC and seven states filed a motion in New York federal court seeking to hold Martin Shkreli in contempt for allegedly violating a court-ordered lifetime ban from the pharmaceutical industry.

Outcome Details

FTC and seven states seek to hold Martin Shkreli in contempt for allegedly violating lifetime pharmaceutical ban

Importance:3/10

Sentiment:

-0.90

regulatoryenforcementmartin_shkrelilifetime_bancompliance

Read the original article

Published by Endpoints News on October 13, 2026 7:04 PM

Read Original